Francesco Del Giudice | Ricerc@Sapienza

Pubblicazioni

Titolo	Pubblicato in	Anno
Surgical Technique and Perioperative Outcomes of the “Sapienza” Urology Residency Program’s Trocar Placement Configuration During Robotic-Assisted Radical Prostatectomy (RARP): A Retrospective, Single-Centre Observational Study Comparing Experienced Attendings vs. Post-Graduate Year I–III Residents as Bedside Assistants	CANCERS	2025
Adjuvant Immune Checkpoint Inhibitors for Muscle-Invasive Urothelial Carcinoma: An Updated Systematic Review, Meta-analysis, and Network Meta-analysis	TARGETED ONCOLOGY	2025
The Role of Butirprost® as an Adjuvant in Enhancing the Effect of Antibiotics in Patients Affected by Chronic Bacterial Prostatitis: A Randomized Prospective Trial	MEDICINA	2025
The impact of preoperative venous thromboembolism on patients undergoing TURBT: Perioperative outcomes and healthcare costs from US insurance claims data	BJUI COMPASS	2025
Oncologic Outcomes of Endoscopic Management of Upper Tract Urothelial Carcinoma: A Systematic Review and Pooled Analysis from the EAU-YAU Urothelial Working Group	EUROPEAN UROLOGY FOCUS	2025
Obesity alters the fitness of peritumoral adipose tissue, exacerbating tumor invasiveness in renal cancer through the induction of ADAM12 and CYP1B1	MOLECULAR ONCOLOGY	2025
Systematic review and meta-analysis of serum total testosterone and luteinizing hormone variations across hospitalized Covid-19 patients	SCIENTIFIC REPORTS	2024
How the Management of Biochemical Recurrence in Prostate Cancer Will Be Modified by the Concept of Anticipation and Incrementation of Therapy	CANCERS	2024
VI‐RADS followed by Photodynamic Transurethral Resection of Non‐Muscle‐Invasive Bladder Cancer vs White‐Light Conventional and Second‐resection: the ‘CUT‐less’ Randomised Trial Protocol	BJU INTERNATIONAL	2024
Blood Extracellular Vesicles beyond Circulating Tumour Cells: A Valuable Risk Stratification Biomarker in High-Risk Non-Muscle-Invasive Bladder Cancer Patients	BIOMEDICINES	2024
Exploring the utility of a NGS multigene panel to predict BCG response in patients with non-muscle invasive bladder cancer	ONCOLOGY RESEARCH	2024
Partial nephrectomy in elderly patients: a systematic review and analysis of comparative outcomes	EUROPEAN JOURNAL OF SURGICAL ONCOLOGY	2024
Cisplatin eligibility in the neoadjuvant setting of patients with muscle-invasive bladder cancer undergoing radical cystectomy	THE ONCOLOGIST	2024
Upper Tract Urothelial Cancer: Guideline of Guidelines	CANCERS	2024
Real-Life Comparative Analysis of Robotic-Assisted Versus Laparoscopic Radical Prostatectomy in a Single Centre Experience	CANCERS	2024
Clinical Validation of the Intermediate-risk Non–muscle-invasive Bladder Cancer Scoring System and Substratification Model Proposed by the International Bladder Cancer Group: A Multicenter Young Academic Urologists Urothelial Working Group Collaboration	EUROPEAN UROLOGY ONCOLOGY	2024
The Role of Mitomycin C in Intermediate-risk Non–muscle-invasive Bladder Cancer: A Systematic Review and Meta-analysis	EUROPEAN UROLOGY ONCOLOGY	2024
The role of re-transurethral resection of bladder tumor in patients with TaHG non muscle invasive bladder cancer	WORLD JOURNAL OF UROLOGY	2024
Risk of Metachronous Upper Tract Urothelial Carcinoma After Ureteral Stenting in Patients With Bladder Cancer	CLINICAL GENITOURINARY CANCER	2024
Exposure to the herbicide 2,4-dichlorophenoxyacetic acid and prostate cancer among U.S. adult men	WORLD JOURNAL OF UROLOGY	2024

1
2
3
4
5
6
7
8
9
10
11
12
seguente ›
ultima »

ERC

LS4_12

Interessi di ricerca

Genito Urinary Oncology
Minimally Invasive Robotic-Assisted Urologic Surgery
Urothelial Solid Neoplasms
Non-Muscle Invasive Bladder Cancer
Muscle-Invasive Bladder Cancer
Upper Tract Urothelial Carcinomas

Progetti di Ricerca

Magnetic Resonance Imaging-Targeted Biopsy for Primary Detection of Prostate Cancer: Magnetic Resonance Imaging (MRI) In-Bore versus MRI-Trans-rectal ultrasound (TRUS) Fusion Technique
Co-expression of Programmed Death Ligand 1 (PD-L1) and markers of Epithelial-Mesenchymal Transition (EMT) on Circulating Tumor Cells (CTCs): a possible immune escape mechanism in urothelial carcinomas of the urinary bladder.